Alternative activation of macrophages (M) during helminth infection is a characteristic feature of the host immune response. Alternatively activated macrophages (AAM) are distinguished from others by high arginase 1 (Arg-1) activity, low nitric oxide (NO), and high interleukin 10 (IL-10) production. In murine models, these cells have been shown to possess anti-inflammatory properties. They have also been implicated in exacerbating a subsequent infection with a secondary pathogen. In this study we used cattle experimentally infected with Fasciola hepatica to monitor the kinetics of IL-4 and IL-10 over the course of infection. Using naïve M in vitro, we examined the effects of exposure to F. hepatica excretory/secretory products (FhepES) alone or in combination with IL-4. Our results suggest that FhepES may work in combination with IL-4 to produce AAM. The effects of FhepES on the subsequent responses to lipopolysaccharide (LPS) and purified protein derivative from Mycobacterium bovis (PPD-B), which are bovine Toll-like receptor 4 (TLR4) and TLR2 antagonists, respectively, were also examined. We found that M stimulated with FhepES together with LPS or PPD-B have reduced NO or gamma interferon production, respectively. The ability of FhepES to produce AAM was found to be heat labile and partially dependent on glycan residues. A possible role for TLR recognition is discussed.
Alternative activation of macrophages (M) is a common feature of the immune response to helminth parasites, and their presence has been shown in a number of model infections, including those caused by Schistosoma mansoni (14) , Taenia crassiceps (25) , Brugia malayi (21) , and Fasciola hepatica (9, 11) . These alternatively activated macrophages (AAM) are distinguished from classically activated macrophages by preferential use of arginase 1 (Arg-1), instead of inducible nitric oxide (13) , to metabolize L-arginine. A number of other markers of AAM have also been identified; these include increased expression of interleukin 10 (IL-10) and the mannose receptor (13) , as well as production of intelectin, chitinases, and chitinase-like proteins (22) .
Immune responses to helminth infections are often polarized toward the Th2 end of the immune spectrum. These polarized responses may be associated with the development of chronic infections while avoiding parasite clearance by the host (20) . Th2-dominated responses have been observed in F. hepatica infection in both mice and the natural ruminant hosts. Antibody production is dominated by the immunoglobulin G1 isotype (5, 23) . In experimentally infected cattle, gamma interferon (IFN-␥) production and cellular proliferation are detected soon after infection in response to both F. hepatica antigen and the mitogen concanavalin A. However, in response to both these stimuli, cellular proliferation and IFN-␥ production decrease as infection progresses, and when an animal enters the chronic stage of infection, these responses are no longer detectable (6) . These highly polarized immune responses may be associated with increased host susceptibility to other pathogens. In a murine model of coinfection with Bordetella pertussis, F. hepatica was responsible for reduced bacterial clearance and specific IFN-␥ production (4) . Infection with F. hepatica has also been shown to have downregulatory effects on Mycobacterium bovis BCG-specific immune responses in cattle (12) . A population of AAM identified in these coinfected animals may be responsible for some of the negative effects on M. bovis BCG-specific immune responses. AAM generated during T. crassiceps infections have been implicated in favoring Leishmania mexicana and Leishmania major replication in T. crassiceps-infected mice (24) .
The nature of the interaction of parasites or parasite products with M is still not fully clear. However, evidence suggests that carbohydrate residues on parasite products are associated with Toll-like receptor (TLR) signaling (15) . There is evidence to suggest that activated M have a limited ability to repolarize in response to differing and sequential signals, such as cytokines, lipopolysaccharide (LPS), or TLR ligands. Experiments using rat-derived M have demonstrated that the first cytokine the cell encounters will determine the response regardless of subsequent stimulation (10) . While other workers have produced evidence showing the functional plasticity of murine M, these M were shown to change their responses following exposure to sequential changes in stimuli (27) .
In this study we present data examining the kinetics of IL-4 and IL-10 over the course of experimental infection. We then examine the interactions of IL-4 and excretory/secretory products (ES), reflecting the microenvironment of an infected host, in activating bovine M in vitro. Examination of the influence of ES on the interaction of TLR 2 (TLR2) and TLR4 stimuli with M reveals a negative interaction, while heat inactivation and oxidation of ES suggests that glycan residues have some role to play in parasite-host interactions.
MATERIALS AND METHODS
Experimental infection and cytokine kinetics. Four castrated Friesian cattle were housed indoors and fed high-quality silage ad libitum at University College Dublin's Lyons Research Estate, County Kildare, Ireland. Animals were experimentally infected with metacercarie as previously described (12) . These infected animals were used to measure the kinetics of IL-4 and IL-10 production.
At the indicated time points, peripheral blood mononuclear cells (PBMCs) from F. hepatica-infected animals were isolated over Ficoll-Histopaque (SigmaAldrich, United Kingdom) and cultured in complete RPMI 1640 (Invitrogen) containing 10% heat-inactivated fetal calf serum (Sigma-Aldrich), 200 U/ml penicillin (Sigma-Aldrich), and 200 g/ml streptomycin (Sigma-Aldrich). Cells were plated, in triplicate, at a density of 1 ϫ 10 5 cells per well in 100-l volumes. For cytokine production, F. hepatica excretory/secretory products (FhepES) were added at a concentration of 10 g/ml with phosphate-buffered saline (PBS) as a control. Following 72 h of incubation, supernatants were harvested and stored at Ϫ20°C until analyzed. All animal work was conducted under license from the Department of Children and Health following approval by the University College Dublin Ethics Committee.
Macrophage isolation, culture, and activation. Blood collected from naïve healthy animals was used for the generation of monocyte-derived macrophages (MDM). Blood was collected into lithium heparin-coated Vacutainers, and isolation of M was performed as described elsewhere (12) . Briefly, PBMCs were isolated from blood by centrifugation over Ficoll-Histopaque (Sigma-Aldrich). ϩ fractions were routinely checked for purity by Giemsa staining. CD14 ϩ fractions were washed twice in complete medium and adjusted to a concentration of 1 ϫ 10 6 cells/ml and added to 96-well plates (Sarstedt) in 200-l volumes. To generate MDM, cells were cultured for 7 days, with the medium changed every second day. Activating molecules were added to mature M in a final volume of 20 l of medium at the indicated concentrations, and cells were incubated for a further 48 h. LPS derived from Escherichia coli 111:B4 (1 g/ml) was used as a TLR4 antagonist (8) . M. bovis purified protein derivative, PPD-B, used at indicated concentrations, was used as a stimulus for TLR2 activity (30) .
Antigen preparation. FhepES were prepared as previously described and purified to remove contaminating endotoxin residues (12) . To heat inactivate FhepES prior to use, samples were heated to 95°C for 15 min (2). Glycan residues were destroyed by oxidizing FhepES samples as described elsewhere (16) .
Macrophage phenotyping. Following stimulation for the indicated period of time, supernatants were removed from M cultures and centrifuged to remove cell debris before storage at Ϫ20°C. Fifty microliters of 1% Triton X-100 was added to each of the wells on the plate, and cells were lysed by shaking for 15 min. Lysates were stored at Ϫ20°C. M phenotyping was performed by measurement of arginase, NO, and acidic chitinase production as described below.
(i) Arginase activity. Cell lysates (50 l) were activated by heating to 55°C for 10 min with 50 l Tris buffer (25 mM Tris-HCl buffer with 10 mM MnCl 2 [pH 7.5]). An equal volume (25 l) of this mixture was added to 0.5 M arginine (pH 9.7) and incubated for 1 h at 37°C. The reaction was stopped by the addition of 400 l of acid stop solution (96% H 2 SO 4 , 85% H 3 PO 4 , and H 2 O at a ratio of 1:3:7), 25 l of 9% isonitrosopriopherone was added and heated to 100°C for 45 min. Optical densities at 570 nm were measured and compared to a urea standard curve, where one unit of enzyme activity is equal to the amount of urea produced in the reaction. Results were expressed as milliunits of activity per 10 6 cells (mU/10 6 cells). (ii) Nitric oxide. Nitric oxide levels were quantified using the Griess reaction. Briefly, 50 l of supernatant was added to 100 l of sulfanilamide solution and incubated in the dark at room temperature for 10 min. One hundred microliters of N-1-napthylethylenediamine dihydrochloride solution was then added and incubated as described above. Optical densities at 570 nm were measured, and nitrate was quantified by comparison with a standard curve.
(iii) Acidic chitinase activity. Chitinase activity was determined using a standard assay (3). Briefly, 10 l of supernatant was added to 40 l of 0.1 M sodium citrate buffer containing 0.025 mM of substrate, 4-methylumbelliferyl-␤-D-N,NЈ,NЉ-diacetylchitobioside (Sigma). The assay was buffered to pH 2.5 specifically to measure acidic chitinase (AMCase) activity only. The reaction mixture was incubated at 37°C for 3 h and stopped by the addition of 200 l of 0.25 M glycine-NaOH (pH 10.5). Fluorescence was measured by excitation at 365 nm and emission at 460 nm. Chitinase activity was quantified by comparison with a standard curve of 4-methylumbelliferone (Sigma), and activity was expressed as nanomoles/hour/milliliter.
Cytokine detection. IFN-␥ was measured using the Bovigam enzyme-linked immunosorbent assay (ELISA) test kit according to the manufacturer's instructions. IL-4 was quantified by a commercial ELISA (Endogen), and values are reported as picograms/milliliter. IL-10 was quantified by an ELISA using paired antibodies (Serotec) as previously described (17) . Briefly, anti-IL-10 capture antibody (clone CC318) was added to wells of a 96-well plate (Nunc) at a concentration of 6 g/ml in carbonate-bicarbonate coating buffer, pH 9.6, and the plate was incubated overnight at room temperature. Plates were washed three times after each step in PBS containing 0.05% Tween 20. After the wells were coated, all incubations were for 1 h at room temperature. The plate was blocked by the addition of PBS containing 0.05% Tween 20 and 1% bovine serum albumin, and samples were added in duplicate. Following this, anti-IL-10 antibody (clone CC320) coupled to biotin was added at a concentration of 2 g/ml. Streptavidin-horseradish peroxidase was diluted to 1/1,000 in blocking buffer and added to the plate for 30 min. Color was developed by the addition of 3,3Ј,5,5Ј-tetramethylbenzidine (TMB) for 10 min, and the reaction was stopped by the addition of 1% H 2 SO 4 . Optical densities were measured at 450 nm. The results are reported as optical density index (ODI) calculated as follows; experimental reading minus background reading multiplied by 1,000.
Statistical analysis. Cytokine, enzyme, and nitric oxide levels were tested for significant differences by the Student t test in the initial activation experiment using ES (Minitab). In experiments using IL-4 and ES and ES with TLR agonists, analysis of variance (ANOVA) (Minitab) was used to detect statistically significant differences.
RESULTS
Th2 cytokine production elicited by FhepES stimulation of lymphocytes from F. hepatica-infected animals. IL-4 and IL-10 production by PBMCs restimulated in vitro with FhepES was examined from four F. hepatica-infected animals over the course of a 12-week infection. Postinfection, IL-4 production peaked between weeks 2 and 6, with levels at week 6 ranging from 135.5 pg/ml to 423 pg/ml. Subsequently, decreasing levels of IL-4 were observed as the infection reaches chronic stages (Fig. 1a) . IL-10 production in the same cultures were initially low with only one of four infected animals producing detectable IL-10 at week 2. By week 6, three of four infected animals were producing detectable levels, and these continued to rise steadily, reaching a peak at week 12 (Fig. 1b) .
Alternative activation of macrophages by a F. hepatica-derived molecule. We generated AAM by exposing MDM from healthy uninfected cattle to FhepES concentration of 20 g/ml (calculated from dose-response curves [data not shown]). High levels of Arg-1 (60.9 mU/10 6 cells), AMCase (30.3 nmol/h/ml), and IL-10 (ODI of 29.3) were produced by FhepES-stimulated cells (Fig. 2) . The levels of Arg-1, AMCase, and IL-10 produced by FhepES-stimulated cells were significantly higher than those in LPS-stimulated cells. IL-10 was also detected in LPS-stimulated cultures. However, the levels of IL-10 produced by FhepES-stimulated M were significantly higher than those produced by LPS stimulation (ODI of 29.3 Ϯ 2.8 versus 12.33 Ϯ 1.01 [P Ͻ 0.005]). LPS incubation resulted in levels of NO significantly higher than those from FhepESstimulated cells (P Ͻ 0.005).
Synergy between FhepES and IL-4 in macrophage activation. The optimal concentration of IL-4 for use in in vitro assays was determined by a dose-response curve. Using arginase and AMCase activity as markers of activation, we found 20 ng/ml to be the optimal dose ( Fig. 3a and b ). We exposed MDM to IL-4 and found upregulation of Arg-1 and AMCase. When cells were treated with IL-4 and FhepES together, we found increased levels of Arg-1 and AMCase ( Fig. 4a and b) . The levels of Arg-1 were found to be significantly greater in 
Effects of FhepES on responses of macrophages to PPD-B and LPS.
To examine the plasticity of M, cells were exposed to increasing concentrations of PPD-B and simultaneously incubated with FhepES, IFN-␥, and IL-10 levels were measured in the culture supernatants. IFN-␥ levels were found to increase as the dose of PPD-B was increased (Fig. 5a ). However, when FhepES was added to parallel cultures, IFN-␥ production was reduced. No significant difference between the lowdose PPD-B culture and the parallel PPD-B-FhepES culture was observed in terms of IFN-␥ production, suggesting that a high dose of PPD-B is required to stimulate IFN-␥ production. IL-10 was produced following PPD-B stimulation alone. Again, the lowest dose of PPD-B alone was not sufficient to induce IL-10 levels above background. The addition of FhepES to parallel cultures resulted in massive release of IL- on January 12, 2018 by guest http://iai.asm.org/ 10, with a four-to fivefold increase. The effect of FhepES on the ability of LPS to classically activate macrophages was evaluated. LPS alone induces high levels of NO ( Fig. 2c and 5c ). The addition of FhepES, however, inhibits this effect (Fig. 5c) . Similarly, FhepES modulates the LPS-stimulated M away from the classical phenotype, instead favoring production of Arg-1 (Fig. 5d) . These results suggest that FhepES has the ability to modulate the phenotype of LPS-and PPD-B-stimulated M. The effects of FhepES are heat labile and partially dependent on glycan residues. To examine the effects of heat inactivation on the capacity of FhepES (heat-inactivated FhepES [Hi-ES]) to activate M, FhepES were heated to 95°C. When Hi-ES were used to stimulate cells, no response could be seen, suggesting that heat inactivation had denatured the components of FhepES responsible for Arg-1, AMCase, and IL-10 production (Fig. 6 ). FhepES were oxidized to destroy glycan residues, Gly-ES, within the parasite material. Stimulation of cells with this revealed a decrease in all parameters measured. While the effects of glycan removal were not as dramatic as heat inactivation, they resulted in a reduction of approximately 50% in IL-10 and AMCase production (P Ͻ 0.05). The reduction in Arg-1 production was the most pronounced with activity falling from 85.01 mU/10 6 cells for FhepES to 18.51 mU/10 6 cells for Gly-ES (P Ͻ 0.005) (Fig. 6a) .
DISCUSSION
Here we demonstrate the production of IL-4, a key Th2 cytokine, by PBMCs of F. hepatica-infected cattle following restimulation in vitro. We also describe the shift from IL-4 production to IL-10 production as infection progresses. This is similar to other helminth infections where chronic infections occur. Previous work detailing the immune response of F. hepatica-infected animals demonstrated a strong Th2 bias, characterized by high immunoglobulin G1 production coupled with poor IFN-␥ release and cellular proliferation by 4 weeks postinfection (5, 6) . The results presented here, describing the kinetics of IL-4 and IL-10 production from animals infected with F. hepatica, add to the knowledge of immune responses to F. hepatica. The presence of IL-10 also explains previous findings, documenting a lack of cellular responsiveness and IFN-␥ production in chronically infected animals (5). Previously published work has demonstrated that Th2 cytokine environments favor the development of AAM (9, 21, 25) , and the presence of IL-4 is thought to play a role in their development. F. hepatica infection in the murine model also favors this, and we have previously shown the presence of AAM in F. hepaticainfected cattle (12) . Over the course of infection, resting M are exposed to parasite-driven IL-4, which favors alternative activation. Our results support this idea, and the data dealing with IL-4 in combination with FhepES suggest there may be synergy between the two. The function of AAM in helminth infections is not fully clear; they have been implicated in a number of roles, including protection from immunopathology (14) , parasite expulsion (1), and direct modulation of lymphocyte responses (19, 26, 28, 29) . A role for AAM in increased susceptibility to coinfection was also demonstrated in T. crassiceps-infected mice (24) . In this model, increased replication of Leishmania major and L. mexicana was due to the presence of AAM in cestode-infected mice and not the absence of Th1 responses. Our results suggest that AAM generated by F. hepatica infection or in vitro exposure to FhepES results in a phenotype that may modulate or simply be nonresponsive to another activating molecule. Incubation with PPD-B, a TLR2 antagonist, together with FhepES resulted in poor IFN-␥ release yet high IL-10 production. These results suggest that IL-10 induced by FhepES is downregulating IFN-␥. This could have implications for coinfections with F. hepatica. We have previously demonstrated that F. hepatica alters the diagnostic capacity of assays designed to detect bovine tuberculosis in coinfected animals. Here we show that the high levels of IL-10 produced by M stimulated by FhepES in the presence of PPD-B could be responsible for the poor skin test responses previously seen in coinfected animals (12) . Modulation of the M response to LPS was also another feature of cells incubated with FhepES. LPS is a potent M activator and signals through TLR4 to produce NO (8) . Here we found a reduction in NO levels in M stimulated with both LPS and FhepES. We also found that Arg-1 production was upregulated even in the presence of LPS. This suggests that the mechanism by which FhepES signals is capable of interfering with LPS signaling. Our results also add to other evidence that M possess a degree of plas- on January 12, 2018 by guest http://iai.asm.org/ ticity in their response to signals promoting classical or alternative activation (27) . However, the various conditions under which this may occur have yet to be explored. These include sequential stimulation, involving removal of the initial stimulus, washing steps of the cells, and finally the addition of subsequent stimuli (27) .
Our results suggest that FhepES may be capable of overriding the effects of TLR2 and TLR4 antagonists on M phenotype. This may occur in one of two ways; alternative activation by FhepES may alter the expression levels of TLR2 or TLR4, or conversely, FhepES may be interacting with one or both of these receptors, leaving them unavailable for additional signaling. The exact method by which helminths interact with the innate immune system is not fully understood, while their ability to modulate many facets of innate immunity is not in question. However, there is growing proof that helminths modulate the host's response though TLR interaction. There is evidence that products derived from early infective S. mansoni larvae can signal through TLR4. In particular, the glycan residues within these extracts were found to be responsible for increased IL-6 and IL-12p40 production (16) . Lewis sugars and other glycans from T. crassiceps have been shown to induce IFN-␥ via TLR signaling from peritoneal murine M (7). Elsewhere a role for TLR2 has also been implicated in immunopathology in S. mansoni infection (18) . Indeed the role of TLR2 was demonstrated to be necessary only in the priming stage of the immune response, suggesting a role for TLR in early recognition of the worm. Our results also point toward a possible interaction with the TLR system during F. hepatica infection. The blockade of other TLR stimuli by FhepES and reduction of effectiveness of Gly-ES point toward this. The majority of interactions between parasite products and the TLR system that have been documented seem to stem from parasite glycoproteins (15) . The overriding Th2 nature of helminth immune responses might be explained by two possible suggestions. The possible presence of molecules other than glycans in FhepES having stronger interactions with the innate immune system or the polarization of the immune response may depend on the strength of the binding of the sugars to TLRs. This phenomenon has been demonstrated recently where antibodies directed against T-cell immunoglobulin mucin TIM-1 had differing effects on the response, with binding by one resulting in increased IFN-␥ and IL-17 in experimental autoimmune encephalomyelitis, while a second antibody resulted in a Th2 response in the same model. These effects were seen to be related to the avidity with which each antibody bound their epitope (31) .
The results presented here suggest that F. hepatica has a strong interaction with the host immune system that may benefit parasite survival. Evidence to suggest a parasite interaction with the TLR system and interference with subsequent signaling is also presented. This has implications for coinfections involving helminths and other pathogens and helps to outline the mechanism behind some of the effects seen in coinfected animals (12) . One important unanswered question is the exact nature of the interaction between F. hepatica or its ES with the innate immune system, although the involvement of glycans is highly likely. Studies involving TLR blockade need to be undertaken to test directly the involvement of these receptors. Ultimately, the identification of these molecules and an understanding of how they direct the immune response will aid the quest for effective antiparasite vaccination strategies.
